Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

NCT05474846 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT05474846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05474846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
November 21, 2022
Completion date
February 28, 2027
Enrollment
169 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, cancer, depression, fatigue, sleep